These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effects of intravenous & oral N-sulfanilyl-N-butyl urea (BZ 55) on blood sugar in diabetics and persons with normal metabolism]. PFEFFER KH; FUCHS KJ; MICHEL W; FOERDER HK Arztl Wochensch; 1957 Mar; 12(12):260-3. PubMed ID: 13410706 [No Abstract] [Full Text] [Related]
3. [Blood protein values and oral antidiabetic drugs; with a contribution to the statistical evaluation of median value differences reported without dispersion parameter]. KUHNE P; SCHULTZ GW Arztl Wochensch; 1957 Feb; 12(5):112-5. PubMed ID: 13402613 [No Abstract] [Full Text] [Related]
4. [Ambulatory treatment with an oral antidiabetic]. ILLIG H; WELLER O Munch Med Wochenschr; 1957 Jan; 99(2):40-5. PubMed ID: 13400084 [No Abstract] [Full Text] [Related]
5. [First experiences with the new oral antidiabetic invenol]. FIALA E; BALASSA M Orv Hetil; 1957 May; 98(21):554-5. PubMed ID: 13452526 [No Abstract] [Full Text] [Related]
6. Experience with an oral antidiabetic drug. MENON KP; MOSES SG J Indian Med Assoc; 1956 Dec; 27(11):391-6. PubMed ID: 13398631 [No Abstract] [Full Text] [Related]
7. Oral preparations of antidiabetic agents; report of a fatal case. FIELD JB; FEDERMAN DD Med Ann Dist Columbia; 1957 Jun; 26(6):297-300. PubMed ID: 13440223 [No Abstract] [Full Text] [Related]
8. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man]. KLOTZBUCHER E Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436 [No Abstract] [Full Text] [Related]
9. Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period. KERLAN M J Tn State Med Assoc; 1957 Feb; 50(2):46-8. PubMed ID: 13399061 [No Abstract] [Full Text] [Related]
10. [Behavior of inorganic phosphorus in blood after intravenous load of glucose in diabetics treated with butylsulfamidurea]. GASTALDI F Arch Sci Med (Torino); 1957 May; 103(5):376-82. PubMed ID: 13445446 [No Abstract] [Full Text] [Related]
11. Clinical tests of the antidiabetic sulfa drugs. EICHBAUM FW Rev Bras Med; 1957 Jan; 14(1):5-11. PubMed ID: 13442028 [No Abstract] [Full Text] [Related]
12. [Blood transaminases as indication of tolerance to antidiabetic sulfanylurea]. PELLEGRINI R Boll Soc Ital Biol Sper; 1956 Dec; 32(12):1454-5. PubMed ID: 13446088 [No Abstract] [Full Text] [Related]
13. [Hepatotoxic effect of chronic oral administration of sulfonamide in therapy of diabetes mellitus]. QUITZOW G; SPIES R; WUNDRAK-WALDHEIM G Wien Med Wochenschr; 1957 Jun; 107(22):464-6. PubMed ID: 13456509 [No Abstract] [Full Text] [Related]
15. Clinical trials with a new antidiabetic. WEILL J; WEIGEL M Strasb Med; 1956 Dec; 7(11):828-38. PubMed ID: 13422046 [No Abstract] [Full Text] [Related]
16. [Oral management of diabetes mellitus with a sulfonyl-urea derivative, BZ 55]. BERTRAM F Nord Med; 1956 Dec; 56(51):1834-7. PubMed ID: 13400309 [No Abstract] [Full Text] [Related]
17. [A new antidiabetic drug, B Z 55]. BILHAN N; KARKALAS Y Turk Tip Cemiy Mecm; 1956 Sep; 22(9):503-17. PubMed ID: 13391990 [No Abstract] [Full Text] [Related]